|
1.
|
Pilli T, Prasad KV, Jayarama S, Pacini F
and Prabhakar BS: Potential utility and limitations of thyroid
cancer cell lines as models for studying thyroid cancer. Thyroid.
19:1333–1342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Alves MLD, Maciel RMB, Valeri FV, Silva
MRDD, Contrera JD, Andrade JM, Llorach-Velludo MA and Iazigi N:
Prediction of malignancy in the solitary thyroid nodule by physical
examination, thyroid scintigraphy, thyroid ultrasound, fine-needle
biopsy and serum thyroglobulin: a prospective study of 110 operated
patients. Arq Bras Endocrinol Metabol. 46:648–653. 2002.(In
Portuguese).
|
|
3.
|
Cerutti JM: Nodule diagnosed as
follicullar patterned lesion: are biomarkers the promise? Arq Bras
Endocrinol Metabol. 51:832–842. 2007.PubMed/NCBI
|
|
4.
|
Zatelli MC, Trasforini G, Leoni S, Frigato
G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E and degli
Uberti EC: BRAF V600E mutation analysis increases diagnostic
accuracy for papillary thyroid carcinoma in fine-needle aspiration
biopsies. Eur J Endocrinol. 161:467–473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Suster S: Thyroid tumors with a follicular
growth pattern: problems in differential diagnosis. Arch Pathol Lab
Med. 130:984–988. 2006.PubMed/NCBI
|
|
6.
|
Segura MEA and Magalhães AV: Galectin-3
immunostaining in thyroid neoplasms. J Bras Patol Med Lab.
41:341–346. 2005. View Article : Google Scholar
|
|
7.
|
Rosa MP: Expression of galectin-3 and
cytokeratin 19 in the epithelial neoplasm of the thyroid gland and
histopathological correlation. Jornal brasileiro de patologia e
medicina laboratorial. 41:61–70. 2005.
|
|
8.
|
Cantara S, Capezzone M, Marchisotta S,
Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF,
Brilli L, Montanaro A and Pacini F: Impact of proto-oncogene
mutation detection in cytological specimens from thyroid nodules
improves the diagnostic accuracy of cytology. J Clin Endocrinol
Metab. 95:1365–1369. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kimura ET, Nikiforova MN, Zhu Z, Knauf JA,
Nikiforov YE and Fagin JA: High prevalence of BRAF mutations in
thyroid cancer: genetic evidence for constitutive activation of the
RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
Cancer Res. 63:1454–1457. 2003.PubMed/NCBI
|
|
10.
|
Li Y, Nakamura M and Kakudo K: Targeting
of the BRAF gene in papillary thyroid carcinoma (review). Oncol
Rep. 22:671–681. 2009.PubMed/NCBI
|
|
11.
|
Xing M, Clark D, Guan H, Ji M, Dackiw A,
Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M and Tufano R: BRAF
mutation testing of thyroid fine-needle aspiration biopsy specimens
for pre-operative risk stratification in papillary thyroid cancer.
J Clin Oncol. 27:2977–2982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hwang J, Shin JH, Han BK, Ko EY, Kang SS,
Kim JW and Chung JH: Papillary thyroid carcinoma with BRAFV600E
mutation: sonographic prediction. Am J Roentgenol. 194:W425–W430.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Hayashida N, Namba H, Kumagai A, Hayashi
T, Ohtsuru A, Ito M, Saenko VA, Maeda S, Kanematsu T and Yamashita
S: A rapid and simple detection method for the BRAF(T1796A)
mutation in fine-needle aspirated thyroid carcinoma cells. Thyroid.
14:910–915. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Yip L, Nikiforova MN, Carty SE, Yim JH,
Stang MT, Tublin MJ, Lebeau SO, Hodak SP, Ogilvie JB and Nikiforov
YE: Optimizing surgical treatment of papillary thyroid carcinoma
associated with BRAF mutation. Surgery. 146:1215–1223. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Nikiforov YE, Steward DL, Robinson-Smith
TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K
and Nikiforova MN: Molecular testing for mutations in improving the
fine-needle aspiration diagnosis of thyroid nodules. J Clin
Endocrinol Metab. 94:2092–2098. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Rowe LR, Bentz BG and Bentz JS: Utility of
BRAF V600E mutation detection in cytologically indeterminate
thyroid nodules. Cytojournal. 3:102006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Salvatore G, Giannini R, Faviana P, Caleo
A, Migliaccio I, Fagin JA, Nikiforov YE, Troncone G, Palombini L,
Basolo F and Santoro M: Analysis of BRAF point mutation and RET/PTC
rearrangement refines the fine-needle aspiration diagnosis of
papillary thyroid carcinoma. J Clin Endocrinol Metab. 89:5175–5180.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Sapio MR, Guerra A, Posca D, Limone PP,
Deandrea M, Motta M, Troncone G, Caleo A, Vallefuoco P, Rossi G,
Fenzi G and Vitale M: Combined analysis of galectin-3 and BRAFV600E
improves the accuracy of fine-needle aspiration biopsy with
cytological findings suspicious for papillary thyroid carcinoma.
Endocr Relat Cancer. 14:1089–1097. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Xing M: Prognostic utility of BRAF
mutation in papillary thyroid cancer. Mol Cell Endocrinol.
321:86–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Lee JH, Lee ES and Kim YS:
Clinicopathologic significance of BRAF V600E mutation in papillary
carcinomas of the thyroid: a meta-analysis. Cancer. 110:38–46.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kwak JY, Kim EK, Chung WY, Moon HJ, Kim MJ
and Choi JR: Association of BRAFV600E mutation with poor clinical
prognostic factors and US features in Korean patients with
papillary thyroid microcarcinoma. Radiology. 253:854–860. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Cohen Y, Rosenbaum E, Clark DP, Zeiger MA,
Umbricht CB, Tufano RP, Sidransky D and Westra WH: Mutational
analysis of BRAF in fine needle aspiration biopsies of the thyroid:
A potential application for the pre-operative assessment of thyroid
nodules. Clin Cancer Res. 10:2761–2765. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Xing MZ, Tufano RP, Tufaro AP, Basaria S,
Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D and Ladenson
PW: Detection of BRAF mutation on fine needle aspiration biopsy
specimens: a new diagnostic tool for papillary thyroid cancer. J
Clin Endocrinol Metab. 89:2867–2872. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Domingues R, Mendonça E, Sobrinho L and
Bugalho MJ: Searching for RET/PTC rearrangements and BRAF V599E
mutation in thyroid aspirates might contribute to establish a
pre-operative diagnosis of papillary thyroid carcinoma.
Cytopathology. 16:27–31. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Chung KW, Yang SK, Lee GK, Kim EY, Kwon S,
Lee SH, Park do J, Lee HS, Cho BY, Lee ES and Kim SW: Detection of
BRAFV600E mutation on fine needle aspiration specimens of thyroid
nodule refines cyto-pathology diagnosis, especially in BRAFV600E
mutation-prevalent area. Clinical Endocrinol (Oxf). 65:660–666.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Jin L, Sebo TJ, Nakamura N, Qian X,
Oliveira A, Majerus JA, Johnson MR and Lloyd RV: BRAF mutation
analysis in fine needle aspiration (FNA) cytology of the thyroid.
Diagn Mol Pathol. 15:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Pizzolanti G, Russo L, Richiusa P, Bronte
V, Nuara RB, Rodolico V, Amato MC, Smeraldi L, Sisto PS, Nucera M,
Bommarito A, Citarrella R, Lo Coco R, Cabibi D, Lo Coco A, Frasca
F, Gulotta G, Latteri MA, Modica G, Galluzzo A and Giordano C:
Fine-needle aspiration molecular analysis for the diagnosis of
papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC
rearrangement. Thyroid. 17:1109–1115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Sapio MR, Posca D, Raggioli A, Guerra A,
Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A,
Rossi G, Fenzi G and Vitale M: Detection of RET/PTC, TRK and BRAF
mutations in pre-operative diagnosis of thyroid nodules with
indeterminate cytological findings. Clin Endocrinol. 66:678–683.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Kim SK, Kim DL, Han HS, Kim WS, Kim SJ,
Moon WJ, Oh SY and Hwang TS: Pyrosequencing analysis for detection
of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
Diagn Mol Pathol. 17:118–125. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Moon HJ, Kwak JY, Kim EK, Choi JR, Hong
SW, Kim MJ and Son EJ: The role of BRAFV600E mutation and
ultrasonography for the surgical management of a thyroid nodule
suspicious for papillary thyroid carcinoma on cytology. Ann Surg
Oncol. 16:3125–3131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Marchetti I, Lessi F, Mazzanti CM,
Bertacca G, Elisei R, Coscio G, Pinchera A and Bevilacqua G: A
morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF
V600E detection as an important tool in pre-operative evaluation of
fine-needle aspirates. Thyroid. 19:837–842. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Bentz BG, Miller BT, Holden JA, Rowe LR
and Bentz JS: B-RAF V600E mutational analysis of fine needle
aspirates correlates with diagnosis of thyroid nodules. Otolaryngol
Head Neck Surg. 140:709–714. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Kim SK, Song KH, Lim SD, Lim YC, Yoo YB,
Kim JS and Hwang TS: Clinical and pathological features and the
BRAF(V600E) mutation in patients with papillary thyroid carcinoma
with and without concurrent Hashimoto thyroiditis. Thyroid.
19:137–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Jo YS, Huang S, Kim YJ, Lee IS, Kim SS,
Kim JR, Oh T, Moon Y, An S, Ro HK, Kim JM and Shong M: Diagnostic
value of pyro-sequencing for the BRAF V600E mutation in
ultrasound-guided fine-needle aspiration biopsy samples of thyroid
incidentalomas. Clin Endocrinol (Oxf). 70:139–144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ
and Qu JM: The BRAF mutation is predictive of aggressive
clinicopathological characteristics in papillary thyroid
microcarcinoma. Ann Surg Oncol. 17:3294–3300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Dujardin F, Pagès JC, Collin C, de Calan
L, Lecomte P and Guyétant S: BRAF V600E mutation in papillary
thyroid carcinoma: prevalence and detection in fine needle
aspiration specimens. Ann Pathol. 30:252–262. 2010.(In French).
|
|
37.
|
Girlando S, Cuorvo LV, Bonzanini M,
Morelli L, Amadori P, Dalla Palma P and Barbareschi M: High
prevalence of B-RAF mutation in papillary carcinoma of the thyroid
in north-east Italy. Int J Surg Pathol. 18:173–176. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Musholt TJ, Fottner C, Weber MM, Eichhorn
W, Pohlenz J, Musholt PB, Springer E and Schad A: Detection of
papillary thyroid carcinoma by analysis of BRAF and RET/PTC1
mutations in fine-needle aspiration biopsies of thyroid nodules.
World J Surg. 34:2595–2603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Kim SW, Lee JI, Kim JW, Ki CS, Oh YL, Choi
YL, Shin JH, Kim HK, Jang HW and Chung JH: BRAFV600E mutation
analysis in fine-needle aspiration cytology specimens for
evaluation of thyroid nodule: a large series in a
BRAFV600E-prevalent population. J Clin Endocrinol Metab.
95:3693–3700. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Guo F, Hou P and Shi B: Detection of BRAF
mutation on fine needle aspiration biopsy specimens: diagnostic and
clinical implications for papillary thyroid cancer. Acta Cytol.
54:291–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Kwak JY, Kim EK, Kim JK, Han JH, Hong SW,
Park TS and Choi JR: Dual priming oligonucleotide-based multiplex
PCR analysis for detection of BRAF(V600E) mutation in FNAB samples
of thyroid nodules in BRAF(V600E) mutation-prevalent area. Head
Neck. 32:490–498. 2010.PubMed/NCBI
|
|
42.
|
Ohori NP, Nikiforova MN, Schoedel KE,
LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L and
Nikiforov YE: Contribution of molecular testing to thyroid
fine-needle aspiration cytology of ‘follicular lesion of
undetermined significance/atypia of undetermined significance’.
Cancer Cytopathol. 118:17–23. 2010.
|
|
43.
|
Moses W, Weng J, Sansano I, Peng M,
Khanafshar E, Ljung BM, Duh QY, Clark OH and Kebebew E: Molecular
testing for somatic mutations improves the accuracy of thyroid
fine-needle aspiration biopsy. World J Surg. 34:2589–2594. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL,
Song KH, Lim SD, Kim WS and Paik NS: Surgical results of thyroid
nodules according to a management guideline based on the
BRAF(V600E) mutation status. J Clin Endocrinol Metab. 96:658–664.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Yeo MK, Liang ZL, Oh T, Moon Y, An S, Kim
MK, Kim KS, Shong M, Kim JM and Jo YS: Pyrosequencing cut-off value
identifying BRAFV600E mutation in fine needle aspiration samples of
thyroid nodules. Clin Endocrinol (Oxf). 75:555–560. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Adeniran AJ, Theoharis C, Hui P, Prasad
ML, Hammers L, Carling T, Udelsman R and Chhieng DC: Reflex BRAF
testing in thyroid fine-needle aspiration biopsy with equivocal and
positive interpretation: a prospective study. Thyroid. 21:717–723.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Pelizzo MR, Boschin IM, Barollo S,
Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC,
Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero
F and Mian C: BRAF analysis by fine needle aspiration biopsy of
thyroid nodules improves pre-operative identification of papillary
thyroid carcinoma and represents a prognostic factor. A
mono-institutional experience. Clin Chem Lab Med. 49:325–329. 2011.
View Article : Google Scholar
|
